tooluniverse-precision-oncology

MEDIUM W011: Third-party content exposure detected (indirect prompt injection risk).

• Third-party content exposure detected (high risk: 0.85). The required workflow (Phase 2/3/5) queries multiple public biomedical sources (e.g., CIViC, ClinVar, COSMIC, GDC/TCGA, PubMed, BioRxiv/MedRxiv, OpenAlex, ClinicalTrials.gov) and then uses their returned text/fields to build the LLM’s report context, which is outsider-authored free text from public web databases at runtime.